OverviewSuggest Edit
Biocon is a global biopharmaceutical company. It manufactures biologics, biosimilar insulins, and antibodies. The company focuses on the areas of diabetes, oncology, immunology, dermatology, ophthalmology, neurology, rheumatology, and inflammatory diseases. It is also involved in the integrated discovery, development, and manufacturing services for small and large molecules, antibody-drug conjugates, and oligonucleotides.
| Type | Public | |
| Founded | 1978 | |
| HQ | Bengaluru, IN | Map |
| Website | biocon.com | |
| Employee Ratings | More |
Recent NewsAll News
- Biocon - Biosimilar Traction Buoys Up Q3, Momentum To Be Key: ICICI Direct
- Biocon - Steady Q2; Generics Business Remains Under Pressure: ICICI Securities
- Biocon Q2 Review - Steady Numbers Amid Better Margins: ICICI Direct
- Global HER2 Inhibitors Market Report 2021-2025 & 2030 Featuring F. Hoffmann-La Roche., Merck, Novartis, Pfizer, Puma Biotechnology, Boehringer-Ingelheim, Mylan, and Biocon
Key People/Management at Biocon
Siddharth Mittal
Kiran Mazumdar Shaw
Arun Chandavarkar
Jonathan Hunt
Shreehas P Tambe
M. Damodaran
Biocon Office Locations
Biocon Financials and Metrics
Biocon Revenue
| INR | |
|---|---|
Revenue (Q1, 2022) | 18.1b |
Gross profit (Q1, 2022) | 12.0b |
Gross profit margin (Q1, 2022), % | 66.1% |
Net income (Q1, 2022) | 1.1b |
Market capitalization (10-Nov-2021) | 414.3b |
Closing stock price (10-Nov-2021) | 347.9 |
| INR | FY, 2019 |
|---|---|
Revenue/Employee | 6.4m |
Biocon Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| AxiCorp GmbH | February 11, 2008 | |
| Bicara Therapeutics Inc | ||
| Biocon Academy | ||
| Biocon Biologics do Brasil Ltda. | ||
| Biocon Biologics FZ–LLC | ||
| Biocon Biologics Healthcare Malaysia SDN. BHD | ||
| Biocon Biologics Inc. | ||
| Biocon Biologics Limited | ||
| Biocon Biologics UK Limited | ||
| Biocon Biosphere Limited |
Biocon Revenue Breakdown
Biocon revenue breakdown by business segment: 28.8% from Research Services, 30.8% from Generics, 37.0% from Biosimilars and 3.4% from Other
Biocon Cybersecurity Score
Biocon Environment, Social & Governance (ESG) Ratings
Biocon Online and Social Media Presence
19.67k Twitter followers
Biocon has 19.67k Twitter Followers. The number of followers has increased 1.1% month over month and increased 2% quarter over quarter
Biocon's Trends
Twitter Engagement Stats for @bioconlimited
9.6k
Tweets
359
Following
19.7k
Followers
36
Tweets last 30 days
7
Avg. likes per Tweet
97.2%
Tweets with engagement
Biocon News and Updates
Biocon - Biosimilar Traction Buoys Up Q3, Momentum To Be Key: ICICI Direct
Biocon - Steady Q2; Generics Business Remains Under Pressure: ICICI Securities
Biocon Q2 Review - Steady Numbers Amid Better Margins: ICICI Direct
Global HER2 Inhibitors Market Report 2021-2025 & 2030 Featuring F. Hoffmann-La Roche., Merck, Novartis, Pfizer, Puma Biotechnology, Boehringer-Ingelheim, Mylan, and Biocon
Biocon Unit To Offer 15% Stake To Serum Institute’s Arm In A Strategic Alliance
Insights on the Automated Insulin Delivery System Global Market to 2026 - Featuring Biocon, Dexcom and Digital Medics Among Others
Biocon Blogs
Biocon Q3FY22 Revenue at Rs 2,223 Cr, Up 18%; EBITDA at Rs 537 Cr, Up 25%; Biosimilars Up 28% at Rs 981 Cr; Research Services Up 10% at Rs 641 Cr; Generics Up 7% at Rs 607 Cr
The USFDA issues a complete response letter for the Biologics License Application (BLA) for insulin Aspart
Biocon Biologics* Partner Viatris Wins U.S. Court Decisions on Sanofi Appeals for Lantus® Device Patents
Clinical Study for Itolizumab in Lupus Nephritis Initiated in India, Post DCGI Approval
Biocon Ltd partners with Tabuk Pharmaceuticals to commercialise its speciality generic medicines in the Middle East
Biocon Enters Prestigious Dow Jones Sustainability Emerging Markets Index
Biocon Frequently Asked Questions
When was Biocon founded?
Biocon was founded in 1978.
Who are Biocon key executives?
Biocon's key executives are Siddharth Mittal, Kiran Mazumdar Shaw and Arun Chandavarkar.
How many employees does Biocon have?
Biocon has 13,500 employees.
What is Biocon revenue?
Latest Biocon annual revenue is ₹73.6 b.
What is Biocon revenue per employee?
Latest Biocon revenue per employee is ₹5.5 m.
Who are Biocon competitors?
Competitors of Biocon include Cipla, Sun Pharma and Idorsia.
Where is Biocon headquarters?
Biocon headquarters is located at 20th KM, Hosur Road, Electronic City, Bengaluru.
Where are Biocon offices?
Biocon has offices in Bengaluru, Cambridge, Dublin, Kuala Lumpur and in 5 other locations.
How many offices does Biocon have?
Biocon has 10 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies